AGIOS PHARMACEUTICALS, INC.【AGIO】Cash flow
Market cap
$1.7B
P/E ratio
| 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Depreciation & amortization | - | - | - | - | - | - | 8 | - | - | - | - | - |
| Stock-based compensation | 3 | 12 | 32 | 42 | 48 | 73 | 72 | 75 | 54 | 49 | 45 | 43 |
| Cash from operations | -56 | -59 | -77 | 39 | -285 | -304 | -371 | -291 | -314 | -309 | -296 | -390 |
| Capital expenditures | -1 | -2 | -20 | -10 | -5 | -7 | -12 | -15 | -6 | -5 | -1 | -2 |
| Cash from investing | -87 | -333 | 128 | -119 | -58 | -274 | 91 | 76 | 1,249 | 243 | 240 | 363 |
| Cash from financing | 124 | 335 | 6 | 170 | 285 | 546 | 290 | 262 | -766 | 2 | 5 | 14 |
| Free cash flow | ||||||||||||
| FCF margin (%) | - | - | - |